[Rapport de recherche] La taille du marché du diagnostic du cancer colorectal devrait passer de 10 374,68 millions de dollars américains en 2022 à 16 996,48 millions de dollars américains d’ici 2028 ; on estime qu'il enregistrera un TCAC de 8,7 % de 2023 à 2028.
Le marché du diagnostic du cancer colorectal est segmenté en fonction de la modalité, de l'utilisateur final et de la géographie. Le rapport offre des informations et une analyse approfondie du marché, mettant l’accent sur des paramètres tels que les moteurs, les tendances, les opportunités et l’analyse du paysage concurrentiel des principaux acteurs du marché dans diverses régions. Il comprend également des analyses de l'impact de la pandémie de COVID-19 dans les principales régions.
Aperçus stratégiques
Aperçus du marché
Les lancements de nouveaux produits stimulent le colorectal
Les principaux acteurs du marché du diagnostic du cancer colorectal fabriquent une large gamme de dispositifs qui contribuent à réduire le fardeau du cancer colorectal et d'autres indications associées telles que les polypes du côlon, la maladie de Crohn, la colite et le syndrome du côlon irritable. En juillet 2022, US Digestive Health (USDH), un réseau de cabinets gastro-intestinaux (GI) de premier ordre, a annoncé la commercialisation de dépistages de coloscopie assistés par IA avec la plus grande installation du pays de modules d'endoscopie GI Genious Intelligent. Ces modules devraient aider les médecins à identifier en temps réel les polypes difficiles à détecter et potentiellement cancéreux. Avec le lancement de cet appareil, les patients du sud-est, du sud-ouest et du centre de la Pennsylvanie peuvent désormais accéder à une coloscopie assistée par l'IA avec des capacités améliorées. En septembre 2020, Olympus Corporation a annoncé le lancement d'ENDO-AID, une plateforme de pointe alimentée par l'intelligence artificielle (IA). La plateforme comprend l'application ENDO-AID CADe (app), une méthode endoscopique assistée par ordinateur pour la détection de différentes affections du côlon. Cette nouvelle plateforme d'IA permet l'affichage en temps réel des lésions suspectes détectées automatiquement et fonctionne en combinaison avec son EVIS X1. Ainsi, les développements fréquents et les lancements de nouveaux produits stimulent la croissance du marché du diagnostic du cancer colorectal.
Informations basées sur la modalité
Sur la base de la modalité, le diagnostic du cancer colorectal Le marché est divisé en tests basés sur les selles et en tests d’imagerie. En 2022, le segment des tests d’imagerie détenait une part plus importante du marché du diagnostic du cancer colorectal et devrait enregistrer un TCAC plus élevé au cours de la période de prévision. L’utilisation des tests d’imagerie dans le diagnostic du cancer colorectal a évolué au cours des dernières années. Les résultats de l'imagerie jouent un rôle déterminant dans la surveillance, le diagnostic, la stadification, la sélection du traitement et la planification du suivi. Les tests d'imagerie consistent à examiner la structure du côlon et du rectum pour détecter la présence de zones anormales. Les examens d'imagerie utilisent des oscilloscopes, des instruments en forme de tube dotés d'une lumière et d'une minuscule caméra vidéo à leur extrémité, insérés dans le rectum. Ces tests analysent l'intérieur du côlon et du rectum à la recherche de zones anormales pouvant être un cancer ou des polypes. Ces tests sont moins souvent utilisés que les tests basés sur les selles et nécessitent plus de préparation préalable et comportent certains risques associés, contrairement aux tests basés sur les selles. Les tests d'imagerie sont en outre classés en coloscopie, colonographie CT, sigmoïdoscopie flexible, endoscopie par capsule et autres.
Le segment de la coloscopie détenait la plus grande part du marché en 2022. Cependant, la colonographie CT devrait croître à un rythme soutenu. rythme plus rapide au cours de la période de prévision. La colonographie CT facilite l'analyse morphologique des déformations de la paroi, fournissant les informations nécessaires à l'évaluation préopératoire du stade T dans le cancer colorectal. Conformément aux lignes directrices des critères d'évaluation de la réponse dans les tumeurs solides (RECIST), la tomodensitométrie est la modalité la plus largement utilisée pour évaluer la réponse au traitement chez les patients atteints de tumeurs métastasées du côlon et du rectum. Les avantages communs de la colonographie CT sont les suivants : elle est rapide et sûre, elle permet de visualiser l'ensemble du côlon et aucune sédation n'est requise pour effectuer le test. Il est recommandé d'effectuer ce test tous les cinq ans chez les patients asymptomatiques présentant un risque moyen.
Marché du diagnostic du cancer colorectal, par modalité - 2022-2028
Informations basées sur l'utilisateur final
En fonction de l'utilisateur final, le marché du diagnostic du cancer colorectal est segmenté en hôpitaux, laboratoires de diagnostic, instituts de recherche sur le cancer et autres. Le segment des hôpitaux représentait la plus grande part de marché en 2022 et devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.
Les acteurs du marché du diagnostic du cancer colorectal adoptent des stratégies organiques telles que le lancement et l'expansion de produits pour étendre leur empreinte géographique et portefeuilles de produits et répondre aux demandes croissantes. Les stratégies de croissance inorganique adoptées par les acteurs du marché leur permettent de développer leurs activités et de renforcer leur présence géographique. De plus, ces stratégies de croissance aident les entreprises à renforcer leur clientèle et à élargir leur portefeuille de produits.
- En décembre 2022, Epigenomics accorde une licence à la technologie des biomarqueurs protéiques pour les tests sanguins du cancer colorectal. La société a obtenu une licence auprès du MD Anderson Cancer Center de l'Université du Texas pour certains brevets et droits technologiques sur les biomarqueurs associés à la détection du cancer colorectal.
- En août 2021, Illumina a acquis GRAIL pour accélérer l'accès des patients à la vie. Sauvegarde du test de détection précoce de plusieurs cancers. Le test sanguin Galleri de GRAIL détecte 50 cancers différents avant qu'ils ne deviennent symptomatiques. L'acquisition de GRAIL par Illumina accélérera l'accès et l'adoption de ce test qui sauve des vies dans le monde entier.
Profils d'entreprise
- Medtronic Plc
- Illumina Inc
- Clinical Genomics Technologies Pty Ltd
- EDP Biotech Corp
- Epigenomics AG
- F. Hoffmann-La Roche Ltd
- Quest Diagnostics Inc
- Novigenix SA
- Siemens Healthineers AG
- Bruker Corp
- Eiken Chemical Co., Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors that are driving growth of the market are increasing prevalence of colorectal cancer and launches of new products.
The US holds the largest market share in colorectal cancer diagnostics market. The growth of the market in the country is because in 2022, more than 600,000 surgeries are performed annually in the US to treat colon diseases. According to the American Cancer Society, the 5-year survival rate for localized colon cancer is 91% and for localized rectal cancer is 90%.
The colorectal cancer diagnostics market majorly consists of the players such as Medtronic Plc, Illumina Inc, Clinical Genomics Technologies Pty Ltd, EDP Biotech Corp, Epigenomics AG, F Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Novigenix SA, Siemens Healthineers AG, Bruker Corp, and Eiken Chemical Co Ltd.
Colorectal cancer diagnostics refers to the tools, kits and test performed on an individual to diagnose colorectal cancer in an individual. This involves series of non-invasive and invasive test to confirm the cancer and its stage based on that treatment will be provided to the patient.
Asia Pacific is expected to be the fastest growing region in the colorectal cancer diagnostics market. Asia Pacific registered as the fastest-growing region in the global colorectal cancer diagnostics market. The market in this region is driven due to rising incidences of colorectal cancer, easy access to the diagnosis for colorectal cancer, and proposing guidelines for the procedures. Also, increasing government funding for research activities in colorectal cancer is expected to propel the growth of the market for colorectal cancer diagnostics in Asia Pacific.
The colorectal cancer diagnostics market, based on modality, is bifurcated into imaging tests and stool based tests. In 2022, the imaging tests segment held the larger share and is expected to grow at a CAGR of 8.8% during the forecast period. Screening and imaging play a vital role in the diagnostics of colorectal cancer to understand the extent of tumor-affected area, that act as a major driving factor for the growth of the imaging tests segment.
The List of Companies - Colorectal Cancer Diagnostics Market
- Medtronic Plc
- Illumina Inc
- Clinical Genomics Technologies Pty Ltd
- EDP Biotech Corp
- Epigenomics AG
- F. Hoffmann-La Roche Ltd
- Quest Diagnostics Inc
- Novigenix SA
- Siemens Healthineers AG
- Bruker Corp
- Eiken Chemical Co., Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
May 2023
Digital PCR (dPCR) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology [Droplet Digital PCR (ddPCR) and BEAMing Digital PCR], Component (Instruments, Reagents and Consumables, and Software and Services), Application (Clinical, Research, and Forensic), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organization), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
May 2023
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography